Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T cells by the viral Tax oncoprotein

Blood

Volumn 111, Issue 9, 2008, Pages 4741-4751

  Pichler, Klemens ^a   Kattan, Tarek ^b   Gentzsch, Juliane ^a   Kress, Andrea K ^a   Taylor, Graham P ^b   Bangham, Charles R M ^b   Grassmann, Ralph ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD137 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TAX PROTEIN; TNFRSF9 PROTEIN, HUMAN;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION; CELL CLONE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN T CELL LEUKEMIA VIRUS 1; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

ANTIGENS, CD137; CELL LINE, TUMOR; CELL PROLIFERATION; CLONE CELLS; GENE EXPRESSION REGULATION; GENE PRODUCTS, TAX; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; NF-KAPPA B; UP-REGULATION;

EID: 44149128211     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-10-115220     Document Type: Article

References (61)

1. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-l in patients with tropical spastic paraparesis. Lancet. 1985;2:407-410.
2. Osame M, Usuku K. Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986;1:1031-1032.
3. Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type G retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77:7415-7419.
4. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A. 1984;81:2534-2537.
5. Mansky LM. In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy. J Virol. 2000;74:9525-9531.
6. Ina Y, Gojobori T, Molecular evolution of human T-cell leukemia virus. J Mol Evol. 1990;31:493-499.
7. Asquith B, Zhang Y, Mosley AJ, et al. In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. Proc Natl Acad Sci U S A. 2007;104:8035-8040.
8. Etoh K, Tamiya S, Yamaguchi K, et al. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res. 1997;57:4862-4867.
9. Gabet AS, Mortreux F, Talarmin A, et al. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene. 2000;19:4954-4960.
10. Grassmann R, Aboud M, Jeang KT. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene. 2005;24:5976-5985.
11. Kashanchi F, Brady JN, Transcriptional and posttranscriptional gene regulation of HTLV-1. Oncogene. 2005;24:5938-5951.
12. Nicot C, Harrod RL, Ciminale V, Franchini G. Human T-cell leukemia/lymphoma virus type 1 nonstructural genes and their functions. Oncogene. 2005;24:6026-6034.
13. Lairmore MD, Franchini G. Human T-Cell Leukemia Virus Types 1 and 2. In: Knipe DM, Howley PM, eds. Field's Virology. Philadelphia, PA: 2007:2071-2105.
14. Mesnard JM, Barbeau B, Devaux C. HBZ. a new important player in the mystery of adult T-cell leukemia. Blood. 2006;108:3979-3982.
15. Bogerd HP, Tiley LS, Cullen BR. Specific binding of the human T-cell leukemia virus type I Rex protein to a short RNA sequence located within the Rex-response element. J Virol. 1992;66:7572-7575.
16. Grone M, Koch C, Grassmann R. The HTLV-1 Rex protein induces nuclear accumulation of unspliced viral RNA by avoiding intron excision and degradation. Virology. 1996;218:316-325.
17. Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7:270-280.
18. Derse D, Mikovits J, Ruscetti F. X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro. Virology. 1997;237:123-128.
19. Robek MD, Wong FH, Ratner L. Human T-cell leukemia virus type 1 pX-I and pX-ll open reading frames are dispensable for the immortalization of primary lymphocytes. J Virol. 1998;72:4458-4462.
20. Arnold J, Yamamoto B, Li M, et al. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood. 2006;107:3976-3982.
21. Fujii M, Chuhjo T, Minamino T, et al. Identification of the Tax interaction region of serum response factor that mediates the aberrant induction of immediate early genes through CArG boxes by HTLV-I Tax. Oncogene. 1995;11:7-14.
22. Akagi T, Ono H, Nyunoya H, Shimotohno K. Characterization of peripheral blood Tlymphocytes transduced with HTLV-I Tax mutants with different trans-activating phenotypes. Oncogene. 1997;14:2071-2078.
23. Schmitt I, Rosin O, Rohwer P, Gossen M, Grassmann R. Stimulation of cyclin-dependent kinase activity and G1 to S-phase transition in human lymphocytes by the human T-cell leukemia/lymphotropic virus type 1 Tax protein. J Virol. 1998;72:633-640.
24. Hasegawa H, Sawa H, Lewis MJ, et al. Thymusderived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat Med. 2006;12:466-472.
25. Marriott SJ, Semmes OJ. Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response. Oncogene. 2005;24:5986-5995.
26. Fraedrich K, Müller B. Grassmann R. The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix. Retrovirology. 2005;2:54.
27. Haller K, Wu Y, Derow E, et al. Physical interaction of human T-cell leukemia virus type 1 Tax with cyclin-dependent kinase 4 stimulates the phosphorylation of retinoblastoma protein. Mol Cell Biol. 2002;22:3327-3338.
28. Pise-Masison CA, Choi KS, Radonovich M, et al. Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein. J Virol. 1998;72:1165-1170.
29. Ishioka K, Higuchi M. Takahashi M, et al. Inactivation of tumor suppressor Dlg1 augments transformation of a T-cell line induced by human T-cell leukemia virus type 1 Tax protein. Retrovirology. 2006;3:71.
30. Xie L, Yamamoto B, Haoudi A, Semmes OJ, Green PL. PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivo. Blood. 2006;107:1980-1988.
31. Silbermann K, Grassmann R. Human T cell leukemia virus type 1 Tax-induced signals in cell survival, proliferation, and transformation. Signal Transduction. 2007;7:34-52.
32. Tsukahara T, Kannagi M, Ohashi T, et al. Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax. J Virol. 1999;73:7981-7987.
33. Copeland KF, Haaksma AG, Goudsmit J, Krammer PH, Heeney JL. Inhibition of apoptosis in T cells expressing human T cell leukemia virus type ITax. AIDS Res Hum Retroviruses. 1994;10:1259-1268.
34. Yang YC, Hsu TY, Lin RH, et al. Resistance to tumor necrosis factor-alpha-induced apoptosis in human T-lymphotropic virus type I-infected T cell lines. AIDS Res Hum Retroviruses. 2002;18:207-212.
35. Waldele K, Silbermann K, Schneider G, et al. Requirement of the human T-cell leukemia virus (HTLV-1 (tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes. Blood. 2006; 107:4491-4499.
36. Hamasaki S, Nakamura T, Furuya T, et al. Resistance of CD4-positive T lymphocytes to etoposide-induced apoptosis mediated by upregulation of Bcl-xL expression in patients with HTLV-I-associated myelopathy. J Neuroimmunol. 2001;117:143-148.
37. Watts TH. TNF/TNFR family members in costimulation of Tcell responses. Annu Rev Immunol. 2005;23:23-68.
38. Wäldele K, Schneider G, Ruckes T, Grassmann R. lnterleukin-13 overexpression by tax transactivation: a potential autocrine stimulus in human T-cell leukemia virus-infected lymphocytes. J Virol. 2004;78:6081-6090.
39. Nagata K, Ohtani K, Nakamura M, Sugamura K. Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type l-encoded p40tax protein in the human T-cell line, Jurkat. J Virol. 1989;63:3220-3226.
40. Princler GL, Julias JG, Hughes SH, Derse D. Roles of viral and cellular proteins in the expression of alternatively spliced HTLV-1 pXmRNAs. Virology. 2003;317:136-145.
41. Rimsky L, Hauber J, Dukovich M, et al. Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein. Nature. 1988;335:738-740.
42. Smith MR, Greene WC. Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev. 1990;4:1875-1885.
43. Heinemann S, Biesinger B, Fleckenstein B, Albrecht JC. NFkappaB signaling is induced by the oncoprotein Tio through direct interaction with TRAF6. J Biol Chem. 2006;281:8565-8572.
44. Hanon E, Hall S, Taylor GP, et al. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood. 2000;95:1386-1392.
45. Pankow R, Durkop H, Latza U, et al. The HTLV-I tax protein transcriptionally modulates OX40 antigen expression. J Immunol. 2000;165:263-270.
46. Harhaj EW, Harhaj NS, Grant C, et al. Human T cell leukemia virus type I Tax activates CD40 gene expression via the N F-kappa B pathway. Virology. 2005;333:145-158.
47. Higuchi M, Matsuda T, Mori N, et al. Elevated expression of CD30 in adult T-cell leukemia cell lines: possible role in constitutive NF-kappaB activation. Retrovirology. 2005;2:29.
48. Ohtani K. Tsujimoto A, Tsukahara T, et al. Molecular mechanisms of promoter regulation of the gp34 gene that is trans-activated by an oncoprotein Tax of human Tcell leukemia virus type I. J Biol Chem. 1998;273:14119-14129.
49. Kim JO, Kim HW, Baek KM, Kang CY. NFkappaB and AP-1 regulate activation-dependent CD137 (4-1BB) expression in T cells. FEBS Lett. 2003;541:163-170.
50. Rivera I, Harhaj EW, Sun SC. Involvement of NF-AT in type I human T-cell leukemia virus Taxmediated Fas ligand promoter transactivation. J Biol Chem. 1998;273:22382-22388.
51. Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat Rev Immunol. 2003;3:609-620.
52. Pollok KE, Kim YJ, Hurtado J, et al. 4-1 BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells. Eur J Immunol. 1994;24:367-374.
53. Iwai K, Mori N, Oie M, Yamamoto N, Fujii M. Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells. Virology. 2001; 279:38-46.
54. DeBenedette MA, Chu NR, Pollok KE, et al. Role of 4-1 BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J Exp Med. 1995;181:985-992.
55. Fukushima N, Nishiura Y, Nakamura T, et al. Involvement of p38 MAPK signaling pathway in IFN-gamma and HTLV-I expression in patients with HTLV-l-associated myelopathy/tropical spastic paraparesis. J Neuroimmunol. 2005;159:196-202.
56. Arnulf B, Villemain A, Nicot C, et al. Human T-cell lymphotropic virus oncoprotein Tax represses TGF-beta 1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis. Blood. 2002;100:4129-4138.
57. Shiao SL, McNiff JM, Pober JS. Memory Tcells and their costimulators in human allograft injury. J Immunol. 2005;175:4886-4896.
58. Sibon D, Gabet AS, Zandecki M, et al. HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CDS cells from death. J Clin Invest. 2006;116:974-983.
59. Wen T, Bukczynski J, Watts TH. 4-1 BB ligandmediated costimulation of human T cells induces CD4 and CDS T cell expansion, cytokine production, and the development of cytolytic effector function. J Immunol. 2002;168:4897-4906.
60. Zheng G, Wang B, Chen A. The 4-1 BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells. J Immunol. 2004;173:2428-2434.
61. Salih HR, Schmetzer HM, Burke C, et al. Soluble CD137 (4-1 BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies. J Immunol. 2001;167:4059-4066.